Collaborative efforts between NYACP and trusted partners to expand educational offerings.
550 First Ave
New York, NY
Jointly provided by the NYU Grossman School of Medicine and the New York Chapter American College of Physicians.
This one-day course will cover state-of-the-art management of patients with cardiovascular risk factors. The course will highlight evidence-based recommendations for the management of patients with cardiovascular risk factors including those with co-morbidities such as diabetes, hypertension, obesity and heart failure.Select presentations will take a deep dive into the importance of SGLT2 and PSCK9 inhibitors in treating cardiovascular risk in patients with or without diabetes. Future therapies targeting biomarkers such as lipoprotein (a) will be discussed, including newly approved therapies targeting ApoC3 in Familial Chylomicronemia Syndrome (FCS) and ANGPTL3 in homozygous familial hypercholesterolemia (HoFH). Participants will also be updated on non-invasive imaging plaque imaging techniques.
Session highlight: A special research presentation on obesity, fat and lipid homeostasis will highlight important ongoing research in the overlap between obesity and cardiovascular disease. The course will provide updates on the role of revascularization, highlighting the ongoing ISCHEMIA trial.
This course will be live-streamed and offered in-person.
Trusted organizations have extended invitations to NYACP members for these events.